Pro les of cognitive de cit and the use of a short neuropsychological battery in di erent types of dementia Eva Bolceková Abstract This work focuses on cognitive de cit pro les and the use of a short neuropsychological battery in patients with di erent types of dementia. Increasing prevalence of dementia syndromes highlights the need of their e cient diagnostics in clinical-psychological practice. Theoretical part of this work presents an overview of neurodegenerative diseases with em- phasis on their neuropsychological presentation. We describe the cogni- tive domains and their neuropsychological examination. We address in detail the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and its experimental Czech version. Research part of the work is based on neuropsychological examinations of 311 patients with cognitive de cit and 118 healthy controls. Patients' group is comprised of subjects with Alzheimer's disease, mild cognitive impairment, vascular cognitive impairment, Lewy Body disease, frontotemporal lobar degene- ration and patients with depression. We assess their cognitive pro les, present sensitivity, speci city, positive and negativne predictive values of RBANS scores for the groups and compare the results of control subjects with the original normative sample. We...

Background: Mild Cognitive Impairment (MCI) is seen as a state between normal aging and dementia, with patients having an increased risk of developing Alzheimer’s disease (AD) and other sorts of dementia. MCI has been linked to a change in gut microbiota which impacts the microbiota-gut-brain axis (MGBA), consequently affecting neurological functions. A way of altering microbiota and thereby promoting cognitive health is through the administration of prebiotics, probiotics, and synbiotics. Aim: This systematic literature review aims to assess the impact of prebiotics, probiotics, and synbiotics on MCI by compiling existing data on the matter. Methods: Three databases - Web of Science, Cochrane, and PubMed - were searched and articles were included based on the following inclusion criteria: (1) randomized clinical trials (RCTs), (2) conducted on adults evaluated with MCI during the study, (3) including a prebiotic, probiotic, or synbiotic intervention of any kind, (4) comparing the intervention with a placebo or control group, (5) written in English, (6) reporting the main outcome of cognitive function using any neuropsychological evaluation test. Results: Five studies were included in the final selection. These studies showed that cognitive function improved after probiotic intervention, significantly affecting several cognitive domains: attention, calculation, orientation in time, and delayed memory. Two studies showed that subjects with low cognitive scores at baseline benefited more from probiotic supplementation compared to high-scoring subjects. Conclusions: Probiotics appear to improve cognition in MCI subjects; however, further research is needed to conclude the effects of prebiotics and synbiotics.

No description available.